Furthermore, Mantovani et al. found that high levels of sMICA could significantly inhibit the function of NK cells in HCC patients, manifested as a reduction in CD107a and NKG2D; the secretion of IFN-γ was also decreased. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.